Commonly studied polymorphisms in inflammatory cytokine genes show only minor effects on mortality and related risk factors in nonagenarians

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 3, 2010, Pages 225-235

  Dato, Serena ^a,b   Krabbe, Karen S ^c   Thinggaard, Mikael ^a   Pedersen, Bente K ^c   Christensen, Kaare ^a   Bruunsgaard, Helle ^c,d   Christiansen, Lene ^a,e  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF CALABRIA   (Italy)

^c Center of Inflammation and Metabolism   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cytokine; Inflammation; Late life survival

Indexed keywords

CYTOKINE;

AGE; AGED; AGING; ARTICLE; CAUSE OF DEATH; COMPARATIVE STUDY; DENMARK; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; RISK FACTOR; SURVIVAL RATE;

AGE FACTORS; AGED, 80 AND OVER; AGING; CAUSE OF DEATH; CYTOKINES; DENMARK; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; SURVIVAL RATE;

EID: 77949501780     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glp210     Document Type: Article

References (83)

1. Vaupel JW, Carey JR, Christensen K, et al. Biodemographic trajectories of longevity. Science. 1998;280:855-860.
2. Nybo H, Petersen HC, Gaist D, et al. Predictors of mortality in 2,249 nonagenarians\the Danish 1905-Cohort Survey. J Am Geriatr Soc. 2003;51:1365-1373.
3. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39:687-699.
4. Störk S, Feelders RA, Van den Beld AW, et al. Prediction of mortality risk in the elderly. Am J Med. 2006;119:519-525.
5. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
6. Bruunsgaard H, Andersen-Ranberg K, Hjelmborg JB, Pedersen BK, Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med. 2003;115:278-283.
7. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
8. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57:M326-M332.
9. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-867.
10. Ray S, Britschgi M, Herbert C, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med. 2007;13:1359-1362.
11. Tracey KJ. The inflammatory reflex. Nature. 2002;420:853-859.
12. Van Den Biggelaar AH, De Craen AJ, Gussekloo J, et al. Inflammation underlying cardiovascular mortality is a late consequence of evolutionary programming. FASEB J. 2004;18:1022-1024.
13. Tracy R. Inflammation and aging: a biologist's perspective. Contribution to NIA Workshop on Inflammation, Inflammatory Mediators and Aging. Bethesda, MD; 2004.
14. Finch CE, Crimmins EM. Inflammatory exposure and historical changes in human life-spans. Science. 2004;305:1736-1739.
15. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244-254.
16. Wiss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med. 2006;12:1005-1015.
17. Bernard V, Pillois X, Dubus I, et al. The-308 G/A tumor necrosis factor-alpha gene dimorphism: a risk factor for unstable angina. Clin Chem Lab Med. 2003;41:511-516.
18. Tso AR, Merino JG, Warach S. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke. 2007;38:3070-3075.
19. Heijmans BT, Westendorp RG, Droog S, Kluft C, Knook DL, Slagboom PE. Association of the tumour necrosis factor alpha-308G/A polymorphism with the risk of diabetes in an elderly population-based cohort. Genes Immun. 2007;3:225-228.
20. Liu D, Metter EJ, Ferrucci L, Roth SM. TNF promoter polymorphisms associated with muscle phenotypes in humans. J Appl Physiol. 2008;105:859-867.
21. Baune BT, Ponath G, Rothermundt M, Riess O, Funke H, Berger K. Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology. 2008;33:68-76.
22. Tedde A, Putignano AL, Nacmias B, Bagnoli S, Cellini E, Sorbi S. Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohort. Neurosci Lett. 2008;446:139-142.
23. Bonafè M, Olivieri F, Cavallone L, et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol. 2001;31:2357-2361.
24. Lio D, Scola L, Crivello A, et al. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10-1082 promoter SNP and its interaction with TNF-alpha-308 promoter SNP. J Med Genet. 2003;40:296-299.
25. Cardelli M, Cavallone L, Marchegiani F, et al. A genetic-demographic approach reveals male-specific association between survival and tumor necrosis factor (A/G)-308 polymorphism. J Gerontol A Biol Sci Med Sci. 2008;63:454-460.
26. Di Bona D, Vasto S, Capurso C, et al. Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev. 2009;8:36-42.
27. Van den Biggelaar AH, Huizinga TW, de Craen AJ, et al. Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp Gerontol. 2004;39:1407-1414.
28. Bruunsgaard H, Christiansen L, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK. The IL-6-174GG>C polymorphism is associated with cardiovascular diseases and mortality in 80-year-old humans. Exp Gerontol. 2004;39:255-261.
29. Bidwell JL, Wood NA, Morse HR, Olomolaiye OO, Keen LJ, Laundy GJ. Human cytokine gene nucleotide sequence alignments: supplement 1. Eur J Immunogenet. 1999;26:135-223.
30. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun. 2001;2:61-70.
31. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369-1376.
32. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 1999;42:1101-1108.
33. Bruunsgaard H, Benfield TL, Andersen-Ranberg K, et al. The tumor necrosis factor alpha-308GG>A polymorphism is associated with dementia in the oldest old. J Am Geriatr Soc. 2004;52:1361-1366.
34. Frayling TM, Rafiq S, Murray A, et al. An interleukin-18 polymorphism is associated with reduced serum concentrations and better physical functioning in older people. J Gerontol A Biol Sci Med Sci. 2007;62:73-78.
35. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639-646.
36. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245-270.
37. Cesari M, Penninx, BW, Pahor M, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:242-248. (Pubitemid 38375337)
38. Danesh J, Kaptoge S, Mann AG, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5:e78.
39. Nybo H, Gaist D, Jeune B, et al. The Danish 1905 cohort: a genetic-epidemiological nationwide survey. J Aging Health. 2001;13:32-46.
40. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53:441-449.
41. Christensen K, McGue M, Petersen I, Jeune B, Vaupel JW. Exceptional longevity does not result in excessive levels of disability. Proc Natl Acad Sci USA. 2008;105:13274-13279.
42. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
43. McGue M, Christensen K. The heritability of cognitive functioning in very old adults: evidence from Danish twins aged 75 years and older. Psychol Aging. 2001;16:272-280.
44. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10:20-30.
45. Jeune B, Skytthe A, Cournil A, et al. Handgrip strength among nonagenarians and centenarians in three European regions. J Gerontol A Biol Sci Med Sci. 2006;61:707-712.
46. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics. 1993;16:180-186.
47. Hajeer AH, Hutchinson IV. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech. 2000;50:216-228.
48. Pociot F, Briant L, Jongeneel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol. 1993;23:224-231.
49. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. PNAS. 1997;94:3195-3199.
50. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics. 1994;39:150-154.
51. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275:18138-18144.
52. Huth C, Illig T, Herder C, et al. Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant-174G>C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann Med. 2009;41:128-138.
53. Sie MP, Sayed-Tabatabaei FA, Oei HH, et al. Interleukin 6-174 g/c promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol. 2006;26:212-217.
54. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1-8.
55. Kurz T, Strauch K, Dietrich H, et al. Multilocus haplotype analyses reveal association between 5 novel IL-15 polymorphisms and asthma. J Allergy Clin Immunol. 2004;113:896-901.
56. Christensen U, Haagerup A, Binderup HG, Vestbo J, Kruse TA, Børglum AD. Family based association analysis of the IL2 and IL15 genes in allergic disorders. Eur J Hum Genet. 2006;14:227-235.
57. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001;112:146-152.
58. Zambon CF, Basso D, Navaglia F, et al. Pro-and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine. 2005;29:141-152.
59. Culpan D, MacGowan SH, Ford JM, et al. Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease. Neurosci Lett. 2003;350:61-65.
60. Levene H. On a matching problem arising in genetics. Ann Math Stat. 1949;20:91-94.
61. Weir BS. Genetic Data Analysis II. Sunderland, MA: Sinauer Associates; 1996.
62. Slatkin M, Excoffier L. Testing for linkage disequilibrium in genotypic data using the expectation-maximization algorithm. Heredity. 1996;76:377-383.
63. Snedecor GW, Cochran WG. Statistical Methods, 8th ed. Ames, IA: Iowa State University Press; 1989.
64. Excoffier L, Laval G, Schneider S. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol Bioinform Online. 2005;1:47-50.
65. Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet. 2008;9:911-922.
66. Franceschi C, Motta L, Valensin S, et al. Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging. 2000;12:77-84.
67. Krabbe KS, Mortensen EL, Avlund K, et al. Genetic priming of a proinflammatory profile predicts low IQ in octogenarians. Neurobiol Aging. 2009;30:769-781.
68. Mulcahy B, Waldron-Lynch F, McDermott MF, et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet. 1996;59:676-683.
69. Wang XY, Hurme M, Jylhä M, Hervonen A. Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish nonagenarians. Mech Ageing Dev. 2001;123:29-38.
70. Ross OA, Curran MD, Rea IM, et al. HLA haplotypes and TNF polymorphism do not associate with longevity in the Irish. Mech Ageing Dev. 2003;124:563-567.
71. Collins JS, Perry RT, Watson B, Jr. et al. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet. 2000;96:823-830.
72. Alvarez V, Mata IF, Gonzalez P, et al. Association between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer disease. Am J Med Genet. 2002;114:574-577.
73. Laws SM, Perneczky R, Wagenpfeil S, et al. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels. Hum Mutat. 2005;26:29-35.
74. Holland AM, van den Brink MR. Rejuvenation of the aging T cell compartment. Curr Opin Immunol. 2009;21:454-459.
75. Yu JT, Tan L, Song JH, et al. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Brain Res. 2009;1253:169-175.
76. Suárez A, Castro P, Alonso R, Mozo L, Gutiérrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation. 2003;75:711-717.
77. Passarino G, Montesanto A, Dato S, et al. Sex and age specificity of susceptibility genes modulating survival at old age. Hum Hered. 2006;62:213-220.
78. Ordovas JM. Gender, a significant factor in the cross talk between genes, environment, and health. Gend Med, 2007;4(suppl B): S111-S122.
79. Cederholm T, Persson M, Andersson P, et al. Polymorphisms in cytokine genes influence long-term survival differently in elderly male and female patients. J Intern Med. 2007;262:215-223.
80. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2:734-744.
81. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol. 2006;147:S232-S240.
82. Alley DE, Crimmins EM, Karlamangla A, Hu P, Seeman TE. Inflammation and rate of cognitive change in high-functioning older adults. J Gerontol A Biol Sci Med Sci. 2008;63:50-55.
83. Pernerger TV. What's wrong with Bonferroni adjustments? BMJ. 1998;316:1236-1238.